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Abstract. 
 
To generate the forces needed for motility, 
the plasma membranes of nonmuscle cells adopt an ac-
tivated state that dynamically reorganizes the actin cy-
toskeleton. By usurping components from focal con-
tacts and the actin cytoskeleton, the intracellular 
pathogens 
 
Shigella flexneri
 
 and 
 
Listeria monocytogenes
 
 
use molecular mimicry to create their own actin-based 
motors. We raised an antibody (designated FS-1) 
against the FEFPPPPTDE sequence of 
 
Listeria
 
 ActA, 
and this antibody: (
 
a
 
) localized at the trailing end of 
motile intracellular 
 
Shigella
 
, (
 
b
 
) inhibited intracellular 
locomotion upon microinjection of 
 
Shigella
 
-infected 
cells, and (
 
c
 
) cross-reacted with the proteolytically de-
rived 90-kD human vinculin head fragment that con-
tains the Vinc-1 oligoproline sequence, PDFPPPPPDL. 
Antibody FS-1 reacted only weakly with full-length vin-
culin, suggesting that the Vinc-1 sequence in full-length 
vinculin may be masked by its tail region and that this 
sequence is unmasked by proteolysis. Immunofluores-
ence staining with a monoclonal antibody against the 
head region of vinculin (Vin 11-5) localized to the back 
of motile bacteria (an identical staining pattern ob-
served with the anti-ActA FS-1 antibody), indicating 
that motile bacteria attract a form of vinculin contain-
ing an unmasked Vinc-1 oligoproline sequence. Micro-
injection of submicromolar concentrations of a syn-
thetic Vinc-1 peptide arrested 
 
Shigella
 
 intracellular 
motility, underscoring the functional importance of this 
sequence. Western blots revealed that 
 
Shigella
 
 infec-
tion induces vinculin proteolysis in PtK2 cells and gen-
erates p90 head fragment over the same 1–3 h time 
frame when intracellular bacteria move within the host 
cell cytoplasm. We also discovered that microinjected 
p90, but not full-length vinculin, accelerates rates of 
pathogen motility by a factor of 3 
 
6
 
 0.4 in 
 
Shigella
 
-
infected PtK2 cells. These experiments suggest that vin-
culin p90 is a rate-limiting component in actin-based 
 
Shigella
 
 motility, and that supplementing cells with p90 
stimulates rocket tail growth. Earlier findings demon-
strated that vinculin p90 binds to IcsA (Suzuki, T.A., S. 
Saga, and C. Sasakawa. 1996. 
 
J. Biol. Chem.
 
 271:21878–
21885) and to vasodilator-stimulated phosphoprotein 
(VASP) (Brindle, N.P.J., M.R. Hold, J.E. Davies, C.J. 
Price, and D.R. Critchley. 1996. 
 
Biochem. J.
 
 318:753–
757). We now offer a working model in which proteoly-
sis unmasks vinculin’s ActA-like oligoproline sequence. 
Unmasking of this site serves as a molecular switch that 
initiates assembly of an actin-based motility complex 
containing VASP and profilin.
 
Address all correspondence to Frederick S. Southwick, Division of Infec-
tious Diseases, Box 100277, University of Florida College of Medicine,
Gainesville, FL 32610. Tel.: (352) 392-2928. Fax: (352) 392-6481.
 
T
 
he 
 
microbial pathogens 
 
Listeria monocytogenes
 
,
 
Shigella flexneri
 
, rickettsia, and vaccinia have
evolved functionally related mechanisms to harness
the forces of actin polymerization for propelling them-
selves within the host cell cytoplasm and for promoting
their cell-to-cell spread (Bernardini et al., 1989; Dabiri et
al., 1990; Heinzen et al., 1993; Cudmore et al., 1995). 
 
Liste-
ria
 
 requires the proline-rich surface protein ActA to ini-
tiate host cell actin assembly (Domann et al., 1992; Kocks
et al., 1992), whereas 
 
Shigella
 
 uses another unrelated cell
wall protein called IcsA (Bernardini et al., 1989; Goldberg
et al., 1993). 
 
Listeria
 
 and 
 
Shigella
 
 move through the cyto-
plasm of PtK2 host cells at speeds as rapid as 0.4 
 
m
 
m/s
(Dabiri et al., 1990; Zeile et al., 1996). Upon reaching the
periphery of the host cell, these bacteria induce the forma-
tion of filopods, and these membrane projections can be
ingested by adjacent cells, allowing these microorganisms
to maximize their infectivity. As 
 
Listeria
 
 move through the
cytoplasm, each of their trailing poles promotes actin fila-
ment assembly into rocket tails (Tilney and Portnoy, 1989;
Dabiri et al., 1990); actin monomers add to the tails at the
bacteria–actin interface, and such localized actin assembly
provides the force for intracellular movement (Sanger et
al., 1992; Peskin et al., 1993). The host cell components re-
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quired for this actin-based motor appear to include con-
stituents of focal contacts, among them actin filaments
(Tilney and Portnoy, 1989; Dabiri et al., 1990), 
 
a
 
-actinin
(Dabiri et al., 1990; Dold et al., 1994), profilin (Theriot et
al., 1994), and the vasodilator-stimulated phosphoprotein
(VASP)
 
1
 
 (Chakraborty et al., 1995). The cell wall protein
ActA is the only known bacterial component required for
 
Listeria
 
 intracellular motility (Domann et al., 1992; Kocks
et al., 1992). ActA contains four oligoproline repeats of
the type FEFPPPPTDE that are essential for binding
VASP (Chakraborty et al., 1995; Pistor et al., 1995). The
consensus sequence (D/E)FPPPPX(D/E)(D/E) is charac-
terized by a stretch of four prolines flanked NH
 
2
 
-termi-
nally by aromatic and acidic residues and COOH-termi-
nally by acidic residues. These features define a new class
of docking sequences designated as actin-based motility-1
(ABM-1) sequences (Purich and Southwick, 1997). This
sequence binds VASP, which in turn contains its own set
of GPPPPP repeats for profilin binding (Reinhard et al.,
1995
 
a
 
). The latter sequence is representative of another
class of oligoproline sequences (ABM-2 sequences) for
profilin binding (Purich and Southwick, 1997).
 
Shigella flexneri
 
 also form actin rocket tails while moving
within the host’s cytoplasm (Bernardini et al., 1989), and
VASP colocalizes with intracellular 
 
Shigella
 
 (Chakraborty et
al., 1995). While the bacterial surface protein IcsA is nec-
essary for 
 
Shigella’s 
 
actin-based motility (Bernardini et al.,
1989; Goldberg et al., 1993; Goldberg and Theriot, 1995),
IcsA bears no obvious structural homology to 
 
Listeria
 
ActA and lacks ABM-1 sequences for VASP binding.
Nevertheless, microinjection of the ActA ABM-1 peptide
FEFPPPPTDE into 
 
Shigella
 
-infected cells blocks bacterial
motility over the same concentration range found to in-
hibit 
 
Listeria
 
 movement (Zeile et al., 1996), indicating that
 
Shigella
 
 may recruit a host cell adapter protein to supply
ABM-1 sequence(s) in place of ActA. 
 
Shigella
 
 infection
has been shown to deplete vinculin from the focal contacts
of host cells (Kadurugamuwa et al., 1991), and IcsA is
known to bind vinculin and to concentrate vinculin to the
back of intracellular bacteria (Suzuki et al., 1996). Using
an antibody directed against the FEFPPPPTDE sequence
of the ActA protein, we have discovered that one or more
cross-reactive proteins concentrate focally at the rearward
pole of motile intracellular 
 
Shigella.
 
 We have identified
the 90-kD vinculin head fragment, which contains an
ABM-1 sequence at its COOH terminus, as the major
cross-reactive protein. Our data suggest that 
 
Shigella
 
 in-
fection results in the proteolysis of intact 120-kD vinculin,
thereby generating a p90 polypeptide that specifically
binds to IcsA and concentrates on the bacterial surface.
Microinjection of the p90 polypeptide, but not intact vin-
culin, into 
 
Shigella
 
-infected PtK2 cells accelerates intracel-
lular motility of the microbes by a factor of three, thus il-
lustrating that the p90 fragment is functionally engaged in
the locomotory process. Our findings indicate that the 90-
kD head fragment of vinculin can serve as the ActA ho-
molog required for 
 
Shigella
 
 actin-based motility, and vin-
culin proteolysis is likely to serve as a molecular switch
 
that unmasks this protein’s ABM-1 oligoproline sequence
to bind VASP on the bacterial surface and to promote the
assembly of an actin-based motor.
 
Materials and Methods
 
Materials
 
PtK2 kangaroo rat kidney cells were grown and infected with 
 
S. flexneri
 
strain M90T, serotype 5, or 
 
L. monocytogenes
 
 10403S, virulent strain sero-
type 1, as previously described (Dabiri et al., 1990; Zeile et al., 1996). Out-
dated platelet-rich plasma was obtained from the local blood bank and
processed within 24 h of the storage expiration date. Thermolysin, poly-
 
l
 
-proline (mol wt
 
average
 
 
 
5
 
 5,600; degree of polymerization 
 
5
 
 57 residues),
aprotinin, leupeptin, pepstatin A, PMSF, and DTT were obtained from
Sigma Chemical Co. (St. Louis, MO). NBD-bodipy-phalloidin was pur-
chased from Molecular Probes, Inc. (Eugene, OR). ActA peptide (CFEF-
PPPPTDE) and vinculin Vinc-1 peptide (PDFPPPPPDL) were synthe-
sized and HPLC purified in the University of Florida Protein Sequencing
Core Lab.
 
Antibodies
 
Anti-vinculin 11-5 mouse monoclonal antibody (Vin 11-5) was obtained
from Sigma Chemical Co. The rabbit serum containing anti-VASP poly-
clonal antibody was a gift of U. Walter (Medical University Clinic,
Wurzburg, Germany). Polyclonal rabbit anti–ActA-peptide antibody was
raised by immunization with a peptide (CFEFPPPPTDE), corresponding
to the ActA’s second oligoproline repeat (Southwick and Purich, 1994) and
coupled to keyhole limpet hemocyanin (Cocalico Biologicals, Reamstown,
PA). Monospecific IgG was then isolated by immuno-affinity chromatog-
raphy on CFEFPPPPTDE peptide coupled to cyanogen bromide-acti-
vated Sepharose 4B (Laine et al., 1988; Laine and Esser, 1989). Anti–
actin-related protein (ARP3) antibody was provided by M. Welch and T.
Mitchison (University of California, San Francisco, CA). Commercial sec-
ondary antibodies conjugated to rhodamine, fluorescein, alkaline phos-
phatase, or horseradish peroxidase were used without further purification.
 
Proteins
 
Human platelet vinculin was obtained from soluble platelet fraction by a
modification of the method of Rosenfeld et al. (1985). Briefly, a vinculin-
enriched fraction was obtained from the 0–35% ammonium sulfate frac-
tionation. The pellet was resuspended in and dialyzed against 20 mM Tris/
acetate, 20 mM NaCl, 0.5 mM EDTA, 0.5 mM EGTA, 0.5 mM PMSF, 15
mM 
 
b
 
-mercaptoethanol, pH 7.6. After centrifugation at 100,000 
 
g
 
 for 1 h,
the protein solution was loaded onto a 1.6 
 
3
 
 30 cm Q-Sepharose (Pharma-
cia Biotechnology Inc., Piscataway, NJ) column equilibrated with the
same buffer and eluted with a 20–500 mM NaCl gradient. The first column
peak (issuing from the column over the 50–100 mM salt range) was highly
enriched in vinculin, as evaluated by SDS-PAGE and Western blotting.
Vinculin was further purified from the pooled fractions of this peak by a
gel filtration column (Superose-12, 10/30; Pharmacia Biotechnology Inc.).
The 90-kD vinculin head fragment was proteolytically cleaved from the
30-kD tail region of purified vinculin using thermolysin (1:250 wt/wt) in
phosphate-buffered saline, pH 7.2, for 20 min at 37
 
8
 
C (Kilic and Ball,
1991), whereupon the solution was adjusted to pH 5.5 with 0.5 M acetic
acid. The head fragment was purified from the tail fragment by Mono S
chromatography (Pharmacia Biotechnology Inc.). The head fragment
failed to remain adsorbed to the column, whereas the p30 tail fragment
eluted at 
 
z
 
200 mM NaCl.
Recombinant human platelet profilin was expressed and purified as de-
scribed elsewhere (Fedorov et al., 1994; Kang et al., 1997).
 
Microinjection Experiments
 
Individual PtK2 cells were microinjected with the antibody, peptides, or
protein, and velocities were measured as previously described (Southwick
and Purich, 1994, 1995; Zeile et al., 1996). Differences in mean velocity
were compared using the nonparametric Wilcoxon test. Immediately be-
fore microinjection, stock samples (10–12 
 
m
 
M) of full-length vinculin and
p90 in 20 mM Hepes, 1 mM EDTA, 1 mM DMSF, 1 mM DTT, pH 7.4,
were diluted with phosphate-buffered saline, pH 7.2, to a final concentra-
tion of 1.2 
 
m
 
M.
 
1. 
 
Abbreviations used in this paper
 
: ABM-1, actin-based motility–1; ARP,
actin-related protein; ECL, enhanced chemiluminescence; PVDF, polyvi-
nylidene difluoride; VASP, vasodilator-stimulated protein. 
Laine et al. 
 
Vinculin Proteolysis in Actin-based Shigella Motility
 
1257
 
Identification of Vinculin p90 Polypeptide
 
Soluble and membrane fractions from 
 
z
 
7 
 
3
 
 10
 
12
 
 human platelets were
prepared as described in Waldmann et al. (1986). The platelet membrane
fractions were extracted and passed through a 1 ml profilin affinity column
as previously described by Reinhard et al. (1995
 
a
 
). The 90-kD polypeptide
was identified as the major ABM-1–containing protein by cross-reaction
with FS-1 anti-ActA antibody. This protein eluted in the flowthrough
fraction that was subjected to two-dimensional IEF, pH range 4–7, and
SDS-PAGE. After electrotransfer to polyvinylidene difluoride (PVDF)
membrane, reaction with the FS-1 antibody was demonstrated using the
alkaline phosphatase method. This protein was then subjected to proteol-
ysis and automated Edman microsequencing.
 
Western Blot Analysis
 
Proteins transferred to the membrane were incubated in Tris-buffered sa-
line (100 mM Tris/HCl, pH 7.5, 0.9% NaCl) containing 5% instant milk
during the blocking and antibody binding steps. Secondary antibodies
used included goat anti–rabbit IgG and rabbit anti–mouse IgG conjugated
to horseradish peroxidase. Bound secondary antibody was visualized us-
ing the enhanced chemiluminescence method (ECL) (Pierce Chemical
Co., Rockford, IL).
 
Vinculin Proteolysis After Shigella Infection
of PtK2 Cells
 
To quantitate the p90 content of PtK2 cells, 150-mm culture dishes con-
taining semiconfluent PtK2 cells were infected with 
 
Shigella
 
 as described
above. At various times (1, 2, and 3 h) after initiating infection, cells were
harvested into a cocktail of protease inhibitors (2 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml
leupeptin, 1 
 
m
 
g/ml pepstatin A, 1 mM PMSF, 1 mM EGTA, 1 mM EDTA,
and 1 mM DTT in 0.1% Triton X-100). The samples were concentrated
with a Centriprep-10 membrane concentrator (Amicon Corp., Danvers,
MA). Samples were standardized with respect to protein concentration,
and then suspended in 2
 
3
 
 SDS sample buffer, boiled for 5 min, and sub-
jected to SDS-PAGE. Uninfected cells and cells exposed to 
 
Escherichia
coli
 
 were extracted and processed in an identical manner.
 
Indirect Immunofluorescence Microscopy
 
PtK2 cells were infected with 
 
Shigella
 
, fixed in 3.7% formalin in a stan-
dard salt solution, permeabilized with 0.2% (vol/vol) Triton X-100, and
stained as previously described (Sanger et al., 1983).
 
Results
 
Anti–ActA-peptide Immunofluorescence
Microscopy Localizes a Cross-reactive Protein at the 
Back of Moving Bacteria
 
VASP was recently shown to concentrate on the surface of
intracellular 
 
Shigella
 
 (Chakraborty et al., 1995). To iden-
tify the host cell ActA-like protein that binds VASP, we
used an antibody designated FS-1, raised against the ABM-1
FEFPPPPTDE sequence of 
 
Listeria
 
 ActA (Southwick and
Purich, 1994). This rabbit polyclonal antibody specifically
reacted with the ActA surface protein in 
 
Listeria
 
 cell wall
extracts and bound to the surface of both intra- and extra-
cellular 
 
Listeria
 
, as demonstrated by immunofluorescence
microscopy. The same antibody failed to cross-react with
 
Shigella
 
 or with cell-free extracts of 
 
Shigella
 
 grown in bac-
terial culture (data not shown). However, immunofluores-
cence micrographs of 
 
Shigella
 
-infected PtK2 cells demon-
strated the presence of a cross-reactive protein or proteins
on intracellular bacteria (Fig. 1, 
 
A–C
 
). Motile bacteria pos-
sessing F-actin rocket tails were identified by bodipy phal-
loidin staining (Fig. 1 
 
A
 
, 
 
rhodamine channel
 
) and by phase
contrast microscopy (Fig. 1 
 
B
 
). The same bacteria were
also stained with the anti-ActA peptide antibody FS-1
(Fig. 1 
 
C
 
, 
 
fluorescein channel
 
). Of 56 bacteria with actin fil-
ament rocket tails, 54 demonstrated focal staining with the
FS-1 anti-ActA antibody. As previously reported (Gold-
berg et al., 1993; Suzuki et al., 1995; D’Hauteville et al.,
1996), the IcsA surface protein is shed from the bacterial
surface into the actin tails, and the cuplike staining pattern
observed in Fig. 1 
 
C
 
 reflects the same distribution that is
observed with IcsA (i.e., the greatest concentration was
found immediately behind the motile bacteria). These ob-
servations suggested that the intracellular 
 
Shigella
 
 bacte-
rium does attract a mammalian ActA homolog to its sur-
face, as suggested by our earlier inhibition experiments
with ABM-1 and ABM-2 oligoproline peptides (Zeile et
al., 1996).
We also found that microinjection of the FS-1 antibody
(at intracellular concentrations as low as 40 nM) into 
 
Lis-
teria
 
-infected PtK2 cells rapidly halted bacterial locomo-
tion, suggesting that the antibody binds to an ActA region
that is critical for actin-based 
 
Listeria
 
 motility. The same
intracellular concentration of the anti-ActA antibody also
rapidly blocked 
 
Shigella
 
 motility in PtK2 cells (Fig. 1 
 
D
 
).
Microinjection of the same concentration of FS-1 antibody
preincubated with twice the molar concentration of the
 
Listeria
 
 ActA ABM-1 peptide (FEFPPPPTDE) failed to
block bacterial intracellular movement (data not shown),
thereby excluding nonspecific inhibition by IgG.
The ActA-binding protein VASP is abundant in plate-
lets (Reinhard et al., 1992), and we expected that one or
more ActA homolog(s) might be present in higher abun-
dance in platelets relative to PtK2 cells. Accordingly, we
used the FS-1 antibody to identify ActA homolog(s) in
platelet membrane extracts that were subjected to IEF
and subsequent SDS-PAGE. After electrotransfer of pro-
teins from the two-dimensional gel, an immunoblot re-
vealed the presence of a major cross-reactive 90-kD
polypeptide with an approximate isoelectric point of 6.0–
6.3 (Fig. 1, 
 
E
 
 and 
 
F
 
). A second, less-abundant 53-kD pro-
tein (with a slightly more acidic isoelectric point) reacted
more weakly with the FS-1 antibody.
 
Identification of the 90-kD ActA Homolog as the 
Vinculin Head Fragment
 
The 90-kD polypeptide (designated hereafter as p90) rec-
ognized by FS-1 anti-ActA peptide antibody was collected
by excising the Ponseau S–stained protein from the two-
dimensional electrophoresis blot. Upon our finding that the
NH
 
2
 
 terminus was blocked, we treated the p90 species with
Lys-C protease. Subsequent gas phase microsequencing
yielded five different peptides (281-GXLRDPSAXPGDAG;
315-ERREILGTXK; 417-IAELXDDPK; 607-LLAVAA-
TAPPTDAPNREEVF; 815-SFLDSGYRI LGA-826), and
all corresponded exactly to the numbered positions within
human vinculin (Weller et al., 1990). That all five matched
vinculin also indicated that no other protein was a major
constituent of the p90 spot excised from the PVDF mem-
brane. Furthermore, Kilic and Ball (1991) reported that
thermolysin digestion of intact human vinculin generated
90-kD head and 30-kD tail fragments; and all of our se-
quenced peptides are present in the 90-kD head fragment
(Fig. 2). Therefore, the FS-1 antibody cross-reacted with
p90 head fragment of vinculin. The identity of the 53-kD 
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Figure 1. Characteristics of
anti–ActA-peptide antibody:
immunolocalization, inhibition
of motility, and identification
of human platelet p90 polypep-
tide. (A) Fluorescence image
of Shigella-infected PtK2 us-
ing bodipy-phalloidin to label
polymerized actin. The thin
white bars demarcate the in-
terface between the bacte-
rium and the trailing actin
rocket tail. (B) Phase-contrast
image of the same field shown
in A. (C) Indirect immunofluo-
rescence image of the same
cells using the FS-1 antibody
raised against the FEFPPP-
PTDE sequence in Listeria
ActA protein. (D) Speed
measurements of Shigella in
PtK2 cells before and after
microinjection of FS-1 anti–
ActA-peptide antibody. The
dashed line indicates the time
of microinjection of antibody
(40 nM calculated intracel-
lular concentration; needle
concentration 0.4 mM). Bars
represent the SEM of 13 dif-
ferent bacteria at each time
point. To compare different
bacteria, values were graphed
as the ratio V(t)/V(0), where
V(t) is the velocity at each time
point and V(0) is the initial
velocity at t 5 0 s. Compari-
sons of actual pre- and postin-
jection speeds also demon-
strated a highly significant
inhibition of Shigella motility
after introduction of the FS-1
antibody (mean preinjection
speed: 0.11 6 0.01 mm/s SEM
n 5 46, vs. postinjection: 0.02
6 0.01 mm/s n 5 48, P ,
0.0001). This same concen-
tration of antibody also signif-
icantly inhibited Listeria in-
tracellular motility (mean
preinjection velocity 0.11 6 0.01 mm/s n 5 14, vs. 0.02 6 0.01 mm/s n 5 18, P , 0.0001). (E) Ponseau S staining of an electroblot of a two-
dimensional IEF/SDS electrophoresis gel. The boxed area shows the major spot identified by FS-1 antibody (raised against ActA pep-
tide). (F) Same electroblot stained with the FS-1 antibody. Two major cross-reactive polypeptides are identified: the 90-kD polypeptide
selected for microsequencing, and a 53-kD polypeptide. Bar, 10 mm.
cross-reactive polypeptide could not be determined by the
same technique, because multiple polypeptides migrated
within the same region (Fig. 1, E and F). It is possible that
this polypeptide represents a further proteolytic degrada-
tion product of vinculin p90, and attempts to further purify
the 53-kD polypeptide are presently underway.
As an additional test of the FS-1 antibody’s specificity
for the 90-kD vinculin fragment, Western blots of thermol-
ysin-cleaved and intact vinculin were performed. Johnson
and Craig (1994, 1995) reported that vinculin’s tail region
is folded over and many binding sites for known actin reg-
ulatory proteins, as well as internal epitopes, are masked
by interactions between the head and tail protein (Fig. 2).
Consistent with this model was our finding that the anti–
ActA-peptide antibody only weakly cross-reacted with
full-length vinculin, yet reacted strongly with the 90-kD
head fragment (Fig. 3). The COOH-terminal region of the
p90 vinculin domain also contains an ABM-1 oligoproline
sequence (PDFPPPPPDL, designated Vinc-1) that bears
sequence homology to the ActA peptide used to generateLaine et al. Vinculin Proteolysis in Actin-based Shigella Motility 1259
the FS-1 antibody. Two other oligoproline sequences
(named Vinc-2 and Vinc-3) are also found in the vinculin
p30 tail (Fig. 2). These proline-rich sequences are dis-
tinctly different from Vinc-1, because they have interven-
ing basic amino acids that were not recognized by the FS-1
antibody, even on Western blots. Our observations indi-
cate that the full-length vinculin refolds to mask its ABM-1
site, after transfer to the PVDF membrane and exposure
to physiologic buffer.
Vinculin’s Head Domain Localizes to the Surface of 
Intracellular Shigella
To learn whether the vinculin head fragment serves as a
mammalian ActA homolog involved in Shigella motility,
bacteria migrating in PtK2 cells were subjected to immuno-
fluorescence microscopy using a monoclonal antibody
(Vin 11-5) directed against vinculin’s head region (Fig. 2).
Motile bacteria were identified by bodipy-phalloidin stain-
ing (rhodamine channel), and the vinculin head fragment
was localized (Fig. 4) by using Vin 11-5 antibody staining
(fluorescein channel). As previously observed with the FS-1
antibody, nearly all motile bacteria (identified by the pres-
ence of actin filament rocket tails) likewise exhibited focal
staining with this anti-vinculin head region antibody (i.e.,
53 of 54 bacteria with actin rocket tails demonstrated focal
staining with Vin 11-5 antibody). This observation, com-
bined with our results with the FS-1 antibody, strongly
suggests that motile bacteria attract a form of vinculin con-
taining the unmasked Vinc-1 oligoproline sequence. As
had been observed with our FS-1 antibody, the mono-
clonal Vin 11-5 antibody did not cross-react with any Shi-
gella proteins (data not shown). Vin 11-5 antibody specifi-
cally cross-reacted with intact vinculin and the p90 head
region on Western blot analysis of PtK2 cell extracts (Fig. 6).
To assess the potential functional significance of the
ABM-1 sequence in vinculin p90 in Shigella motility, we
then examined the inhibitory properties of the synthetic
microinjected Vinc-1, a synthetic peptide based on the vin-
culin ABM-1 oligoproline sequence PDFPPPPPDL. As
noted above, this sequence is located at the COOH termi-
nus of the p90 head fragment and shows strong homology
to the oligoproline sequences of Listeria ActA (Fig. 2).
Zeile et al. (1996) observed that microinjection of the
ActA ABM-1 peptide FEFPPPPTDE arrested intracellu-
lar Shigella motility, and the Vinc-1 peptide likewise inhib-
ited intracellular bacterial movement in PtK2 cells. Com-
plete inhibition was observed at an estimated intracellular
concentration of 800 nM Vinc-1 peptide (mean velocity
preinjection 0.11 6 0.05 mm/s, mean and standard devia-
tion, n 5 44 versus 0.00 mm/s, n 5 44 postinjection) (Fig.
5). Further examination revealed that a 10-fold higher
concentration of Vinc-1 peptide was required (Fig. 5, in-
set) to produce the same level of inhibition observed with
the ActA ABM-1 peptide (i.e., half-maximal inhibition
was observed at 0.5 mM for Vinc-1 versus 0.05 mM for the
ActA ABM-1 peptide). Introduction of poly-l-proline (in-
tracellular concentration, 1 mM) failed to inhibit motility,
thereby excluding any nonspecific inhibitory effect (Zeile
et al., 1996).
The Vinculin Head Fragment Is Generated after 
Shigella Infection
Although present in outdated platelets, the p90 vinculin
head fragment was not detected in cell-free extracts of un-
infected PtK2 cells. Using the high sensitivity ECL detec-
tion method, Western blot analysis indicated that rela-
tively high concentrations of full-length, 120-kD vinculin
were present in PtK2 cells extracts (Fig. 6 A), and even
prolonged exposure of the autoradiograms failed to dem-
Figure 2. Structural organization of human vinculin. Full-length
vinculin has a rigid 90-kD head region and a 30-kD tail region de-
fined by a proteolytic cleavage site. As shown, the tail region is
folded to indicate the latent binding site for F-actin as proposed
by Johnson and Craig (1995). Below is a linearized representa-
tion of human vinculin indicating the reported binding regions
and the proteolytic cleavage site that generates the p90 head and
p30 tail fragments. The head fragment binds monoclonal anti-vin-
culin 11-5 antibody (Kilic and Ball, 1991), talin (Price et al.,
1989), and a-actinin (Wachsstock et al., 1987). The location of the
IcsA binding site on vinculin’s head fragment has not been deter-
mined. The tail fragment contains the sites for binding F-actin
(Johnson and Craig, 1995) and paxillin (Turner et al., 1990). Hu-
man vinculin also has an ABM-1 sequence (residues 840–849)
named Vinc-1 located at the COOH terminus of the p90 frag-
ment generated from vinculin by limited digestion with thermol-
ysin, and included for comparison is the second ABM-1 repeat of
Listeria ActA (residues 269–278). Also shown are the residues
(including the conservative substitution of D for E) shared by the
two sequences. The p30 tail contains two other oligoproline se-
quences (Vinc-2 and Vinc-3) that fail to fulfill the consensus fea-
tures of ABM-1 homology sequences.
Figure 3. Anti–ActA-peptide
identification of the p90 fragment
from digested human vinculin.
Full-length human vinculin (lanes
2 and 4) and thermolysin-
digested (lanes 1 and 3) were
separated by SDS-PAGE and
transferred to PVDF mem-
brane. Lanes 1 and 2 are the
Coomassie blue stain of the
membrane, whereas lanes 3 and
4 are a set of duplicate samples reacted against the FS-1 anti–
ActA-peptide antibody. Note the p90 fragment of the digested
human vinculin (lane 3) is strongly recognized by the antibody,
whereas, the full-length molecule shows very faint recognition
(lane 4). Lane M contains molecular weight markers.The Journal of Cell Biology, Volume 138, 1997 1260
onstrate any vinculin p90. However, vinculin p90 was ob-
served in extracts of PtK2 cells that had been infected with
Shigella for 3 h (Fig. 6 A). The time course of p90 genera-
tion upon Shigella infection was also examined (Fig. 6 B).
The vinculin p90 polypeptide was formed and persisted
throughout the period over which Shigella are typically
observed to move within the cytoplasm of PtK2 cells (i.e.,
1–3 h after the initiation of infection). Densitometry scans
of our autoradiograms revealed that the p90 proteolytic
fragment represented 5.6–7.7% of the total vinculin in Shi-
gella-infected PtK2 cells. To exclude the possibility that
proteolysis was being stimulated by extracellular bacteria,
PtK2 cells were exposed to a similar number of E. coli, and
then incubated for 3 h. While closely related to S. flexneri,
E. coli lacks the 220-kb virulence plasmid that permits Shi-
gella to enter host cells, and therefore remains extracellu-
lar. Infection with E. coli failed to generate the p90 frag-
ment in PtK2 cells (Fig. 6 B). Comparisons of Coomassie
blue–stained extracts from Shigella-infected and -unin-
fected bacteria also demonstrated that there were no no-
ticeable changes in the abundance of other proteins in this
molecular weight range, either before or after Shigella in-
fection (Fig. 6 A, left 2 lanes). Western blots of uninfected
and infected cell extracts, using an anti–a-actinin anti-
body, likewise revealed no differences in a-actinin pro-
teolysis (data not shown) in uninfected versus infected
cells. These observations indicate that the generation of
vinculin p90 did not simply arise from generalized proteol-
ysis in infected PtK2 cells. In addition, phase-contrast mi-
croscopy revealed no discernible differences in morphol-
ogy of uninfected and infected PtK2 cells, again indicating
that over the time course of the infection, the host cells
maintained their normal cytoarchitecture.
Figure 5. Effect of Vinc-1
peptide on Shigella speed.
Representative experiment
showing Shigella flexneri
speed measurements before
and after introduction of the
Vinc-1 peptide. Arrow indi-
cates time of microinjection
of 800 nM Vinc-1 peptide,
calculated as the intracellular
concentration. This experi-
ment is representative of
multiple determinations (mean preinjection velocities: 0.11 6
0.01, SEM, n 5 44, vs. postinjection: 0.00 6 0.01 n 5 44, P ,
0.0001). Inset demonstrates the concentration dependence of
Vinc-1 peptide inhibition. The relative values V(t)/V(0) were de-
termined as described in Fig. 1 D. Bars represent the (SEM) for
24–44 observations.
Figure 4. Immunofluorescence microscopy of Shigella-infected
PtK2 cells using anti-vinculin antibody. (A) Fluorescence image
of Shigella-infected PtK2 cells using bodipy-phalloidin to label
polymerized actin. The thin white lines demarcate the junction
between the bacterium and the actin rocket tail. The asterisk
identifies a bacterium that has a small focal cluster of F-actin. (B)
Phase-contrast image of the same field as shown in A. (C) Indi-
rect immunofluorescence micrograph of the same cells using the
anti-vinculin 11-5 antibody (monoclonal antibody directed against
the head fragment). Note that this anti-vinculin antibody local-
izes to the F-actin tails and to the focal F-actin cluster at one end
of the bacterium identified by the asterisk. (D) An additional flu-
orescence image of Shigella-infected PtK2 cells using bodipy-
phalloidin. (E) Same cell visualized by indirect immunofluores-
cence using the vin11-5 antibody. Bar, 10 mm.Laine et al. Vinculin Proteolysis in Actin-based Shigella Motility 1261
Microinjected p90 Head Fragment, but
Not Intact Vinculin, Markedly Accelerates Shigella 
Intracellular Motility
Based on our Western analysis of Shigella-infected PtK2
cells, we hypothesized that cells containing slowly moving
bacteria may be suboptimal with respect to the intracellu-
lar concentrations of the vinculin p90. To test this predic-
tion, purified platelet p90 (needle concentration 5 1.2 mM;
estimated intracellular concentration 5 0.12 mM) was in-
troduced into PtK2 cells by microinjection. Cells were cho-
sen that contained Shigella moving at slow speeds (i.e.,
those with rates of 0.02–0.06 mm/s). Within 30 s after mi-
croinjection, all moving bacteria began to increase their
rates of locomotion (Fig. 7), and within 60 s, they reached
velocities that were greater than three times their preinjec-
tion rates (Fig. 7 B, V(t)/V(0)). To our knowledge, this is
the first observation of stimulated Shigella locomotion by
the addition of a fragment of vinculin. In some cases, even
previously stationary bacteria began to move at rapid rates
(Fig. 7 A, middle curve).
The difference between the mean preinjection (0.05 6
0.01 mm/s, SEM, n 5 31) and the mean postinjection veloc-
ity (0.17 6 0.01 mm/s, n 5 56) was highly significant (P ,
0.001). Introduction of identical concentrations of full-
length vinculin p120 failed to cause any significant change
in bacterial migration speeds (Fig. 7, A and B), and we ob-
tained mean preinjection speeds of 0.04 6 0.01 mm/s,
SEM, n 5 24 versus postinjection speeds of 0.04 6 0.01
mm/s, n 5 28. Introduction of a twofold greater concentra-
tion of p120 vinculin (needle concentration 2.2 mM, esti-
mated intracellular concentration 0.22 mM) also failed to
accelerate Shigella intracellular motility.
Discussion
Because locomoting Shigella and Listeria mimic the acti-
vated state of the leading edge of nonmuscle cells, these
pathogens are powerful tools for dissecting the molecular
machinery of actin-based motility. Transposon mutation
studies identified the cell wall protein IcsA as a necessary
component for Shigella-induced actin assembly (Bernar-
dini et al., 1989), and expression of only IcsA on the sur-
face of E. coli stimulates actin-based motility in Xenopus
oocyte extracts (Goldberg and Theriot, 1995). Therefore,
IcsA is required for the assembly of actin filaments to pro-
pel  Shigella through the cytoplasm. The IcsA protein,
however, exhibits no homology to the ActA protein,
which was found to be a critical component for Listeria ac-
tin-based motility. In particular, IcsA contains none of the
ABM-1 VASP-binding sites. Nonetheless, like its counter-
part Listeria, Chakraborty et al. (1995) demonstrated that
Shigella attracts VASP to its surface, and we have con-
firmed focal binding of VASP to the trailing pole of mi-
grating bacteria by using anti-hVASP antibody (Laine,
R.O., W. Zeile, F. Southwick, and D.L. Purich, unpub-
lished observations). VASP also has a tandem series of
three GPPPPP (or ABM-2) sequences for profilin binding,
and microinjection of the synthetic GPPPPP peptide
blocks Shigella actin-based motility (Zeile et al., 1996).
Moreover, we have confirmed that this octadecapeptide
GPPPPP-triplet binds to profilin using fluorescence spec-
troscopy (Kang et al., 1997). These findings indicate that
VASP and profilin are key components in the Shigella ac-
tin-based motor.
How then is VASP attracted to the surface of Shigella?
We and others have proposed that the IcsA protein must
Figure 6. Shigella infection induces the production of the 90-kD
vinculin head fragment. (A) Western blots of PtK2 extracts from
uninfected and infected cells using anti-vinculin clone 11-5. Left
lanes, Coomassie blue–stained samples; right lanes, ECL-devel-
oped Western blots. A 120-kD cross-reactive polypeptide (full-
length vinculin) is evident in both extracts. However the 90-kD
head fragment is detected only in the infected cell extract. Cells
were infected for 3 h before generation of the extract. (B) Time
course of p90 formation after Shigella infection. Note the appear-
ance of the p90 band within 1 h of infection. Far right lane shows
extract from PtK2 cells infected for 3 h with a similar number of
E. coli.
Figure 7. Effects of the p90 head fragment and intact vinculin on
speed of Shigella motility in PtK2 cells. (A) Individual Shigella
bacteria migrating in PtK2 cells before and after microinjection
of the p90 head fragment or intact vinculin (estimated intracellu-
lar concentrations 0.12 mM, needle concentrations 1.2 mM).
Dashed line represents the time of microinjection. Two examples
of bacteria exposed to the p90 fragment are shown. In one in-
stance the bacterium was stationary before microinjection (lower
s). After introduction of p90, the bacterium began rapidly accel-
erating to a speed of 0.2 mm/sec. (B) Relative velocity values be-
fore and after microinjection of the same concentrations of the
p90 and vinculin depicted in A. V(t)/V(0) values were deter-
mined as described in the Fig. 1 D. Bars represent the standard
error of n 5 12 bacteria. All motile bacteria in each microinjected
cell were analyzed before and after microinjection.The Journal of Cell Biology, Volume 138, 1997 1262
bind an ActA-like adapter protein containing one or more
ABM-1 sequences to bind VASP. Vinculin is known to
bind on the surface of intracellularly motile Shigella (Ka-
durugamuwa et al., 1991; Suzuki et al., 1996), and IcsA is
capable of binding the head fragment of vinculin (Suzuki
et al., 1996). However, vinculin’s role in generating actin
rocket tails needed for Shigella motility in host cells re-
mained to be elucidated. Suzuki et al. (1996) proposed
that vinculin might serve to bind F-actin and thereby pro-
mote cross-linking of actin filaments. Our experiments
strongly support a role for the p90 head fragment as an
ActA homolog that attracts VASP. Vinculin p90 fulfills
the following essential features of an ActA homolog: (a)
an ability to bind to IcsA on the surface of Shigella, (b)
possession of an ActA-like ABM-sequence PDFPPPP-
PDL for VASP binding (Brindle et al., 1996), (c) the ca-
pacity to be generated by vinculin proteolysis in Shigella-
infected cells, and (d) the ability to accelerate actin-based
motility of Shigella when introduced into infected cells.
These properties suggest a mechanism for assembly of an
actin-based motor (Fig. 8). First, proteolysis generates the
90-kD head, allowing vinculin’s newly exposed VASP-
binding sites to link VASP to the surface of Shigella. Sec-
ond, IcsA has recently been shown to have a considerably
higher affinity for the p90 head fragment than for intact
vinculin (Suzuki et al., 1996) suggesting that vinculin pro-
teolysis may also unmask vinculin’s IcsA binding site.
Therefore, the p90 head fragment would be expected to be
preferentially attracted to Shigella’s surface. Third, bind-
ing of p90 to the surface of Shigella could then attract
VASP to the same polarized location, followed by the con-
centration of profilin via the 20–24 ABM-2 sites found on
the VASP tetramer. Brindle et al. (1996) used GST fusion
protein fragments of vinculin (residues 836–940) to dem-
onstrate binding to VASP, and this region of vinculin con-
tains the ABM-1 sequence. The oligoproline sequences
present in the tail region failed to bind VASP (Brindle et
al., 1996).
Very recently, Sechi et al. (1997) convincingly demon-
strated that most actin filaments within bacterial rocket
tails are organized into long, cross-linked arrays. Their
findings disagree with those of Tilney and Portnoy (1989)
and Tilney et al. (1992a,b) who observed much shorter ac-
tin filaments in Listeria rocket tails. Based on their find-
ings, Sechi et al. (1997) proposed the existence of a poly-
merization zone on the bacterial surface that accelerates
filament assembly without increasing spontaneous nucle-
ation or the capture of new filaments. Kang et al. (1997)
have likewise proposed a cluster model for concentrating
VASP and profilin into narrow zone on the trailing pole of
motile bacteria. They suggest that profilin tethered within
this zone may reach submillimolar concentrations. Re-
cently, Perelroizen et al. (1996) suggested that profilin
promotes assembly by increasing the efficiency of actin
monomer addition to the barbed ends of growing fila-
ments, and they conclude that this process need not in-
volve profilin-catalyzed exchange of actin-bound nucle-
otide. Our scheme (Fig. 8) now offers a mechanism for
using vinculin p90 as an adapter molecule for concentrat-
ing VASP and profilin in a similar polymerization zone on
the surface of Shigella. In a sense, the IcsA–p90 complex
replaces the function of ActA, but further investigation is
warranted to determine how other actin regulatory pro-
teins bind to ActA and the IcsA–p90 complex.
The potent inhibitory action of a synthetic Vinc-1 pep-
tide on Shigella intracellular motility also supports the
conclusion that this ABM-1 site is functionally engaged in
the motile process. Zeile et al. (1996) obtained apparent
inhibitory constants (i.e., the concentration needed to in-
hibit motility by 50%) of 0.05 and 6 mM for the Listeria
Figure 8. A working model for vinculin proteolysis and the as-
sembly of the Shigella actin-based motility complex. Laine et al. Vinculin Proteolysis in Actin-based Shigella Motility 1263
ABM-1 peptide (Phe-Glu-Phe-Pro-Pro-Pro-Pro-Thr-Asp-
Glu), and the ABM-2 peptide (Gly-Pro-Pro-Pro-Pro Pro),
respectively. In the present study, we obtained an approxi-
mate inhibitory constant of 0.5 mM for the vinculin ABM-1
peptide (Asp-Phe-Pro-Pro-Pro-Pro-Pro-Asp-Leu) (Fig.
5). This indicates that VASP binds to the Vinc-1 ABM-1
peptide about 10 times more weakly than the correspond-
ing ActA sequence. This may explain why Listeria form
rocket tails having a greater F-actin content than Shigella
rocket tails. It is very unlikely that our ABM-1 peptides
exert their inhibitory actions by binding to Src SH3 do-
mains. The latter interact with two classes of oligoproline
ligands, designated as the PLR1 and RLP2 sequences: AP-
PPLPRR, and RALPPLP, respectively (Feng et al., 1994).
Positively charged guanidinium groups on PLR1 and
RLP2 interact with an essential carboxyl group located on
SH3 domains, and this charge neutralization is an essential
binding interaction. The negatively charged ABM-1 se-
quences most likely interact with one or more cationic
sidechains on VASP. Given the diametrically opposite
charge interactions for binding of SH3 domains to their
ligands and VASP to ABM-1 peptides, any interaction be-
tween ABM-1 peptides and Src SH3 domains is doubtful.
While our studies indicate that the vinculin p90 is a com-
ponent of the Shigella actin-based motor, other homolo-
gous proteins may also participate. In particular, zyxin
possesses several ABM-1 sequences (Reinhard et al.,
1995b; Purich and Southwick, 1997), but zyxin is about 10–
30 times less abundant than vinculin in nonmuscle cells
(Beckerle, 1986). Our findings demonstrate that vinculin
p90 is clearly present at the trailing pole of motile Shigella,
and zyxin may also play an analogous role as an adapter.
In view of a recent study suggesting that Shigella motility
is unimpaired in the vinculin-deficient cell line 5.51 (Gold-
berg, 1997), one might propose that zyxin is fulfilling this
role. However, Western blot analysis of 5.51 cell extracts
using the Vin 11-5 monoclonal antibody (directed against
the head region of vinculin) reveal several truncated vin-
culin head polypeptides. Furthermore, analysis of vinculin
messenger mRNA in 5.51 cells detects a message spanning
the entire p90 head region of vinculin (Southwick, F., E.
Adamson, D. Purich, unpublished findings). In fact the
nM p90 concentrations required for Shigella motility (Fig.
7), may fall below the detection limits of Western blot
analysis.
Platelet extract experiments have recently identified a
complex involving the ARPs as another potential compo-
nent of the actin motor (Welch et al., 1997). This complex
may be attracted by the high concentrations of profilin
(Machevsky et al., 1994) concentrated by both VASP and
another VASP-like protein, Mena (Gertler et al., 1996), at
the back of Listeria. Similarly, Shigella’s ability to attract
VASP raises the possibility that the ARP complex may be
a component of Shigella’s actin-based motor; however,
preliminary experiments using an anti-ARP3 antibody
failed to disclose the presence of ARP3 on the surface of
Shigella migrating in the cytoplasm of PtK2 cells (data not
shown).
Identification of the p90 vinculin head fragment on the
surface of intracellular Shigella also raises questions about
the abundance of this proteolytic fragment in host cells.
Western blot analysis fails to detect the p90 proteolytic
fragment in uninfected PtK2 cells, but this head fragment
is known to accumulate in aging platelets (Reid et al.,
1993). The latter finding probably accounts for the obser-
vation that zyxin is the only VASP-binding protein in fresh
platelets (Reinhard et al., 1995b). Intracellular infection
by Shigella appears to be required to generate the vinculin
p90 fragment in PtK2 cells, and our studies suggest pro-
teolysis may serve as one molecular switch that unmasks
the vinculin ABM-1 site. The coincident appearance of
p90 over the same time frame as Shigella motility, as well
as the absence of generalized proteolysis, point to vinculin
proteolysis as a likely key step in the generation of Shi-
gella’s  actin-based motor. Furthermore, the profound
functional consequences of generating the p90 vinculin
fragment are dramatically illustrated by microinjecting
this product into infected PtK2 cells. Introduction of the
p90 head fragment, but not full-length vinculin, consis-
tently resulted in the acceleration of Shigella intracellular
speeds by a factor of three. These experiments suggest that
the p90 vinculin head fragment is a rate-limiting compo-
nent of Shigella’s actin-based motor and that supplement-
ing the cell with this product allows Shigella to stimulate
the formation of actin filaments. The inability of intact vin-
culin to enhance intracellular bacterial motility is also con-
sistent with our working model (Fig. 8), which suggests
that the unmasking of vinculin’s ABM-1 site is critical for
generating Shigella’s actin-based motor.
Uninfected cells are apt to engage multiple pathways for
unmasking VASP binding sites on vinculin and related ac-
tin cytoskeletal components. Our FS-1 antibody recog-
nizes vinculin’s ABM-1 binding site for VASP, yet fails to
stain focal contacts. By contrast, anti-vinculin antibody
recognizes different epitopes on the head region and local-
izes to focal contacts (data not shown). These observations
suggest that vinculin’s binding sites for VASP in resting
cells are likely to be fully masked. In response to host cell
regulatory signals, either vinculin proteolysis or some
other nonproteolytic route(s) for unmasking the ABM-1
site may serve as molecular switches for activating or re-
modeling localized actin assembly. For example, Weekes
et al. (1996) showed that acidic phospholipids inhibit the
intramolecular association between the NH2-terminal head
region and the COOH-terminal tail. The conformational
flexibility of vinculin and its ability to become incorpo-
rated into focal contacts may also be regulated by phos-
phorylation. The vinculin tail region contains several serine
and threonine residues that are appropriately flanked by
residues typically recognized by protein kinases A and C
and other kinases involved in signal transduction. These
structural characteristics make vinculin an ideal candidate
for integrating metabolic signals that may lead to the reor-
ganization of the actin cytoskeleton. Our experiments with
Shigella extend the concept that changes in vinculin struc-
ture may serve as a critical molecular switch for activating
the assembly of actin filaments needed to generate the
forces for cell motility.
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